A fragmented $20B market, dual medical-cosmetic revenue, and retiring physician owners create ideal conditions for dermatology consolidation. Here is how to execute.
Find Dermatology Practice Platform TargetsDermatology is among the most consolidated healthcare specialties in private equity, driven by high margins, cash-pay cosmetic revenue, and thousands of independent practices owned by physicians approaching retirement. Roll-up platforms acquire and integrate multiple practices under an MSO structure, centralizing billing, HR, and marketing while preserving clinical independence. Buyers targeting $1M–$5M revenue practices can build meaningful EBITDA bases that command 6–8x multiples at exit.
Independent dermatology practices trade at 4–7x EBITDA, while institutional-scale platforms command 8–12x from strategic or PE buyers. The arbitrage between acquisition and exit multiples, combined with EBITDA expansion through shared services and cosmetic revenue growth, makes dermatology one of the most compelling roll-up opportunities in lower middle market healthcare today.
Minimum $1.5M EBITDA
Platform practices need sufficient cash flow to absorb integration costs, support debt service, and fund add-on acquisitions without immediate margin pressure.
2+ Licensed Dermatologists On Staff
Multi-physician practices reduce key-person risk, enable scheduling scale, and signal an established clinical culture attractive to future add-on providers.
Diversified Payer Mix Under 40% Medicare
Balanced commercial, cash-pay cosmetic, and Medicare revenue reduces reimbursement compression exposure and supports stable, predictable EBITDA through economic cycles.
Modern EMR and Scalable Practice Infrastructure
Platform practices must support centralized billing integration; legacy or siloed systems create costly delays and limit the efficiency gains driving roll-up returns.
Geographic Proximity to Existing Locations
Add-ons within 30–60 miles of platform practices enable shared staffing, centralized management oversight, and cross-referral volume without duplicating administrative infrastructure.
Single-Physician Practice with Retiring Owner
Solo practices owned by retiring dermatologists offer favorable pricing and motivated sellers willing to accept earnouts and transition support agreements to protect patient continuity.
Established Cosmetic Revenue Stream
Add-ons with existing Botox, filler, or laser revenue accelerate cash-pay EBITDA growth and benefit immediately from platform-level marketing and patient acquisition systems.
Clean Malpractice and Compliance History
No pending medical board actions, resolved malpractice claims, and current tail coverage are non-negotiable to protect platform liability and satisfy institutional lender requirements.
Build your Dermatology Practice roll-up
DealFlow OS surfaces off-market Dermatology Practice targets with seller signals — the foundation of every successful roll-up.
Centralized Revenue Cycle Management
Consolidating billing and collections across all practices reduces denials, accelerates reimbursement, and can improve net collections rate by 5–10 percentage points platform-wide.
Cosmetic Revenue Expansion
Introducing or scaling Botox, fillers, and laser aesthetics at medical-only add-on locations converts underutilized chair time into high-margin, cash-pay revenue with no insurance friction.
Shared Back-Office and HR Infrastructure
Platform-level HR, credentialing, compliance, and vendor contracts eliminate redundant overhead across acquired practices, directly expanding EBITDA margins at each add-on location.
Physician Recruitment and Mid-Level Leverage
Adding PA or NP providers under supervising dermatologists increases patient capacity and revenue per physician, reducing key-person dependency while improving practice scalability.
Dermatology roll-up platforms typically exit to larger PE sponsors or strategic acquirers at 8–12x EBITDA once the platform reaches $5M–$10M in consolidated EBITDA across 5–10 locations. Physician equity rollovers and earnout structures align seller-operators with platform growth, improving retention and strengthening the exit narrative. Maintaining clean financials under the MSO structure, diversified payer mix, and documented same-store EBITDA growth are the primary value drivers at recapitalization.
Most states require a Management Services Organization (MSO) structure where a non-physician entity manages business operations while a physician-owned PC or LLC retains clinical control, satisfying corporate practice of medicine laws.
Equity rollover into the platform, competitive base compensation, performance bonuses tied to practice-level EBITDA, and preserving clinical autonomy are the most effective retention tools post-acquisition.
Single-physician add-ons with retiring owners typically trade at 4–5x EBITDA. Multi-physician practices with cosmetic revenue and strong payer contracts can command 5–7x depending on market and competitive dynamics.
Most PE sponsors require $3M–$5M minimum platform EBITDA, typically representing 4–8 locations, before pursuing recapitalization. Consistent same-store growth and physician retention materially improve exit valuation.
More Dermatology Practice Guides
DealFlow OS surfaces off-market platform targets with seller motivation scores. Free to join.
Find platform targets — freeNo credit card required
For Buyers
For Sellers